Study S000499

Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT02909933
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 30
Start: 2015-07
Primary completion: 2015-10
Lead sponsor: University Medical Centre Ljubljana
Conditions: Polycystic Ovary Syndrome; Obesity
Interventions: DRUG:liraglutide; DRUG:metformin and liraglutide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

The main outcome was change in body weight. [Patient's body weight was measured at the base point and after 12 weeks of clinical trial.]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0022935	Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial. Jensterle M, BMC endocrine disorders	2017	Randomized trial	PMID 28143456 DOI	cites ClinicalTrials.gov:NCT02909933; registry reference DERIVED:28143456